Leadership Team

George Prendergast, PhD - CEO and Chairman

George Prendergast, PhD

George C. Prendergast, PhD is President and CEO of Lankenau Institute for Medical Research, CEO of LIMR Development, Inc., and Editor-in-Chief for Cancer Research. With twenty years of expertise in cancer research and drug discovery, Dr. Prendergast brings a distinctive viewpoint that is informed by the academic and pharmaceutical research cultures. He has published over 165 peer-reviewed papers and has over 35 patents or patents pending. His achievements have been recognized by awards from the American Cancer Society and the Pew Scholar in the Biomedical Sciences program. Dr. Prendergast has served as CEO for three start-up companies including OncoRx Inc., which was sold to a biopharma company.

A native of Philadelphia, Dr. Prendergast attended the University of Pennsylvania where he received his BA magna cum laude in Biochemistry in 1983. He received advanced degrees from Yale University (MS, Molecular Biophysics and Biochemistry, 1984) and Princeton University (PhD, Molecular Biology, 1989). Dr. Prendergast worked in the Department of Cancer Research at Merck before being appointed in 1993 to the faculty of The Wistar Institute. In 1999, his main effort moved to The DuPont Pharmaceutical Company where he served as Senior Director of the Cancer Research Group. In 2002, Dr. Prendergast moved his laboratories at Wistar and DuPont to join the faculty of LIMR as a Professor, and eventually President and CEO in 2004.

Melvin Reichman, PhD - President and CSO

Melvin Reichman, PhD

Dr. Melvin Reichman received his PhD in Neuroscience from the University of Rochester Center for Brain Research in 1985 under an NRSA Fellowship. He did his postdoctoral studies as NRSA-NIDA Fellow at the Department of Pharmacology, University of Wisconsin Medical School at Madison. His specialty areas include behavioral psychopharmacology, receptor biology and enzymology, in vitro biochemical pharmacology and nuclear receptors. Dr. Reichman has held several line-management leadership positions in pharma. These include: Head, Cellular Pharmacology Laboratory at G.D. Searle; Head of Molecular Pharmacology Laboratory at Berlex Biosciences; Director of New Leads Discovery at Ligand Pharmaceuticals; Head of Drug Discovery Operations at Oncogene Science and Director and HTS Project Planning and Management at DuPont Pharma. At each site, he has had a significant impact in improving the efficiency and productivity of new leads discovery and in progressing HTS hits to lead candidates. He is an acknowledged expert in automation and technology deployment for pharmaceutical R&D. Dr. Reichman has co-authored 26 publications in the field and has given dozens of invited talks on all aspects of drug discovery from concept to clinic.

Tam Mai-Nguyen, MBA - Treasurer

Tam Mai-Nguyen, MBA

Tam Mai-Nguyen, MBA, received the Bachelor of Science in Accountancy from Villanova University in 1988. She received the Master of Business Administration from Saint Joseph's University in 1998. Ms. Nguyen has twenty years of accounting and financial experience in a medical research and healthcare setting. Prior to taking the position of Director of Finance at LIMR, she served as Controller of Main Line Health System Diversified Services. She currently serves as the elected Treasurer of LIMR Chemical Genomics Center, Inc. (LCGC). In collaboration with the Presidents and Boards of Trustees, Ms. Nguyen provides long range strategic financial planning for LIMR and LCGC.

 

Brian T. Corbett, Esq. - Vice President, General Counsel and Secretary

Brian Corbett, Esq. has practiced health law exclusively since 1984. Immediately prior to joining Main Line Health in 1994 as Senior VP and General Counsel, he was the Director of Legal Services for Franciscan Health System, Group East. Mr. Corbett received his law degree from Catholic University of America, Washington, DC (1984) and his undergraduate degree from Saint Joseph's University (1981). Mr. Corbett is a member of the American Health Lawyers Association, the Pennsylvania Society of Healthcare Attorneys and the Health Lawyers Section of the New Jersey Hospital Association.

J. Todd Abrams, PhD - Board Member

J. Todd Abrams, PhD

Todd Abrams, PhD was formerly the Director of Philanthropy and Business Development at the Lankenau Institute for Medical Research (LIMR), where among other responsibilities he oversaw the technology development initiatives, allowing him to contribute to healthcare through science. Prior to joining LIMR, he was Executive Director, New Product Development at Meniscus Limited, a medical education and publishing company. Dr. Abrams received a BA in biology from Lafayette College in Easton, PA, and his PhD in immunology from the University of Pennsylvania. After receiving his PhD, he spent over a decade performing cancer research, with positions at The Wistar Institute, the University of Miami School of Medicine, and Allegheny University of the Health Sciences (now Drexel Medical School). Dr. Abrams is currently a consultant while also serving as President of the Foundation for Research into Diseases of Aging (FRIDA). He is on the Board of Directors of BioStrategy Partners and chairs the All Partners Committee of BioLaunch 611+ Keystone Innovation Zone.

Pat Weeks - Advisory Board Member

Pat Weeks

Founder of Weeks Consulting LLC, Ms. Weeks clients include high achieving individuals and entrepreneurial organizations representing a broad range of interests. Ms. Weeks is currently Chair Emeritus of the Board of BioStrategy Partners, a nonprofit organization dedicated to the development of startup bioscience companies. She is a practice manager with JF Smith Associates; and consults with the New Jersey Technology Council, Health Research Canada, the World Bank and the National Cancer Institute, as well as a number of startup companies in the Philadelphia region. As the former Vice President for Planning and Business Development of the Fox Chase Cancer Center, Ms. Weeks had responsibility for strategic planning, technology transfer, legal affairs and policy development. She is Past President of the Association of University Technology Managers (AUTM) and has served as President-Elect, President and Past President, VP for Professional Development as well as the VP of the Eastern Region of that organization. Ms. Weeks has served on numerous planning committees and task forces in her tenure as a member of AUTM and is the 2006 Awardee of the Bayh-Dole Award in recognition of her leadership and contributions to the national and international practice of academic technology transfer.